Notably, patients who achieved pathological complete response exhibited significantly lower SIRT3 expression, with a hazard ratio of 17.98 for survival—highlighting a paradoxical, context-dependent role of SIRT3 in breast cancer [134]. The gene discussed is SIRT3; the disease is breast cancer.